(Sharecast News) - Drugmaker Astrazeneca posted another solid earnings beat on Thursday, with year-to-date revenue and profits both rising and core earnings per share up 14%, alongside a further step‑up in late‑stage pipeline momentum.
Total revenues for the nine months ended 30 September increased 7% to $46.88bn, driven by $43.96bn of...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE